The Ibrexafungerp Tablets, cataloged under National Stock Number 6505-01-700-7178, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Scynexis Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-700-7178 |
| Primary Part Number | NDC75788-0115-04 |
| Item Name | Ibrexafungerp Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Scynexis Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC75788-0115-04 PRIMARY | Scynexis Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM2277950 | 5/1 Secondary reference Defense Medical Standardization Board |
| 1628881 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-700-7178 is a Ibrexafungerp Tablets, manufactured by Scynexis Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-700-7178 has 1 manufacturer part number on file: NDC75788-0115-04 (Scynexis Inc).
Key specifications for NDC75788-0115-04: Special Features: INDICATED FOR THE TREATMENT OF ADULT AND POST-MENARCHAL PEDIATRIC FEMALES WITH VULVOVAGINAL CANDIDIASIS (VVC); ARE PURPLE, OVAL, BICONVEX SHAPED TABLETS DEBOSSED WITH 150 ON ONE SIDE AND SCYX ON THE OTHER SIDE; EACH TABLET CONTAINS 150 MG IBREXAFUNGERP (EQUIVALENT TO 189.5 MG OF IBREXAFUNGERP CITRATE); TABLETS ARE PACKAGED IN POLYVINYL/POLYVINYLIDENE CHLORIDE CHILD-RESISTANT BLISTER PACKS, FOUR (4) TABLETS PER PACK; STORE TABLETS AT 20 C TO 25 C (68 F TO 77 F). BRIEF EXPOSURE TO 15 C TO 30 C (59 F TO 86 F) PERMITTED (SEE USP CONTROLLED ROOM TEMPERATURE); SHELF LIFE OF 36 MONTHS.; Part Name Assigned by Controlling Agency: IBREXAFUNGERP TABLETS; 150 MG PER TABLET; 4S. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.